DUBLIN--(BUSINESS WIRE)--The "Cell Counting Market by Product (Instruments (Spectrophotometer, Hemocytometer, Flow Cytometer, Hematology Analyzers), Consumables (Reagent, Microplate)), Cancer, Stem Cell Research, End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global cell counting market is estimated to reach USD 14.50 billion by 2025 from USD 10.49 billion in 2020, at a CAGR of 6.7% during the forecast period.
Market growth is largely driven by growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.
The research application segment commanded the largest share of the market in 2019.
On the basis of application, the cell counting market is segmented into research, medical, and industrial applications. In 2019, research applications accounted for the largest share of the market. Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.
The research institutes segment commanded the largest share of the cell counting market in 2019.
On the basis of end-users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users. In 2019, research institutes accounted for the largest share of the market. The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies.
The Asia Pacific region to register the highest growth in the global cell count market during the forecast period.
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization are supporting market growth in the Asia Pacific.
- Funding for Cell-Based Research
- Rising Incidence of Chronic and Infectious Diseases
- Growing Biotechnology and Biopharmaceutical Industries
- Development of Enhanced Solutions and Improved Image Analysis
- Growing Use of High-Throughput Flow Cytometry and Automated Hematology Analyzers
- High Cost of Cell Analysis Instruments
- Applications of Cell Counting in Personalized Medicine
- Growth in Stem Cell Research
Dearth of Skilled Professionals in Clinical Laboratories
- Danaher Corporation
Thermo Fisher Scientific
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Agilent Technologies, Inc.
Boule Diagnostics Ab
Siemens Healthineers Ag
F. Hoffmann-La Roche Ag
Nexcelom Bioscience Llc
- Logos Biosystems, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/dlqdqr